In the pet supplement market, suppliers are responding to a more informed consumer base and stricter regulatory expectations by investing in novel ingredients, delivery innovation and clinical substantiation.
Innomalous, an India-based manufacturer and exporter specializing in natural private-label pet food, treats and supplements, recently identified its top pet health supplement trends for 2026. According to the report, joint and mobility support continues to draw the highest volume of interest across age groups and breed types, driven by growing awareness of joint health across age groups and breed types and rising pet longevity. Gut and digestive wellness, linked by consumers to immunity, mood and nutrient absorption, is a close second, spurred by food sensitivities and stress-related gut issues.
Anxiety and behavioral wellness, skin and coat, immunity and oral health round out the leading areas pet parents are most interested in, noted Innomalous. In short, pet parents are looking to support their pets' well-being before problems arise.
“Pet parents today are far more proactive about their pets’ well-being,” noted the report. “Online queries reveal clear patterns of concern, most of which mirror the same wellness concerns seen in human wellness trends.”
Ingredients gaining traction
On the ingredient side, Rachel Nye, chief innovation scientist at Enlivenwell, points to two emerging standouts. The first is lemon balm, particularly in standardized forms such as Bluenesse, which she describes as suited for supporting a focused calm. Demand is being pulled in part from the human side of the market, where stress, burnout and sleep disruption have made calming nootropics a growth category.
Pet anxiety follows a similar trajectory — driven by separation issues, noise sensitivity and the challenges of urban pet life — and formulators are bringing those same ingredient solutions across the aisle.
The second ingredient is propolis, which Nye calls a "horizon ingredient" for pet health, citing its potential applications in supporting immunity, oral health and topical healing. She points to Promunel, a standardized propolis, as an example of how the ingredient can be deployed with precision. Here again she noted, crossover from the human supplement space is a primary demand driver, reinforced by the heightened awareness of immune health that followed the COVID-19 pandemic and recent winter virus seasons.
Both ingredients reflect a pattern emerging across the broader market: consumer familiarity with an ingredient from their own supplement routines precedes and accelerates demand for that ingredient in pet products.
Palatability and bioavailability shape format decisions
When it comes to translating an effective ingredient into a viable product, Nye is direct: palatability is non-negotiable. Salmon flavor profiles remain a consistent performer. But palatability is only half the equation. Bioavailability — how efficiently an ingredient is absorbed and utilized — is equally critical, particularly from a commercial standpoint.
"Established and known ingredient bioavailability helps shape the cost of goods and offers more precision with dosing and uptake," Nye said. "Bioavailability studies are essential. This saves brands money in the long term."
The delivery format chosen for a product directly affects both variables. Chews and treat-like formats have grown in popularity because they solve the palatability problem while also fitting naturally into daily feeding routines, a behavioral factor that drives compliance and repeat purchase. Powders and liquids offer flexibility. Innovative delivery formats, such as liquids, may also enhance bioavailability for specific ingredient categories, adding a functional rationale beyond consumer preference.
According to Innomalous, today's pet parents are doing more research and expecting more from labels than they were even a few years ago. They want recognizable ingredients, transparent sourcing and benefit language that is clear without being clinical. They are, in effect, bringing the expectations they have for their own supplement regimens to products they buy for their pets. Brands that lean into that dynamic with simple ingredient lists, palatable formats and evidence-backed claims are better positioned for sustained market performance.
Regulatory pressure raises the bar on claims
As the pet supplement category grows in visibility and sales, regulatory scrutiny is increasing. The question of how companies develop and substantiate claims for new products and ingredients is no longer peripheral — it is central to how credible brands distinguish themselves in a crowded market.
Nye’s emphasis on clinically studied, standardized ingredients speaks directly to this shift. Standardized extracts, paired with published bioavailability data, give formulators the documentation they need to support specific claims. It is a discipline increasingly expected not just by regulators, but by retailers and distributors evaluating which products to carry.
“I see brands being more mindful and conservative with claims, which includes building substantiation for claims to mitigate short- and long-term risk,” Nye said.
Suppliers and formulators who can pair ingredient novelty with clinical credibility — and communicate both clearly to the consumer — are setting the pace for where the pet supplement segment is headed next.
Rachel Nye is a concept-to-shelf innovation scientist who guides pet supplement brands through the full product development process, from ideation through market launch. She also designs and oversees cost-effective clinical research studies. She can be reached at [email protected].
